title: Novel oral taxane therapies: recent Phase I results.
abstract: The oral taxanes are analogues of existing taxanes with a possible broad range of antitumor activity. They also have the potential advantages of ease of administration, better efficacy and lesser toxicity than currently available taxanes. These drugs have been used in several Phase I clinical trials, the methodology and results of which will be reviewed here.
authors.affiliation: Department of Hematology & Oncology, Tufts University School of Medicine, Boston, MA 02111, USA.
authors.forename: John Paul
authors.initials: JP
authors.lastname: Flores
authors.affiliation: Section of GI Cancers & Experimental Therapeutics, Tufts University School of Medicine, Boston, MA 02111, USA.
authors.forename: M Wasif
authors.initials: MW
authors.lastname: Saif
keywords: BMS-275183; DHP107; ModraDoc001; milataxel; oral taxanes; ortataxel; tesetaxel